Unraveling the complex story of CD11c and granzyme B within HBV-related HCC has the potential to identify potential therapeutic targets, and decipher distinct roles in HBV-related HCC progression and prognostic tools, pushing the tide toward improved clinical outcomes for patients. The gene discussed is ITGAX; the disease is hepatocellular carcinoma.